129 related articles for article (PubMed ID: 35316569)
21. Incidence and risk factors for Central Nervous System thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: a single-centre cohort study.
Duarte X; Esteves S; Neto AM; Pereira F
Br J Haematol; 2016 Jul; 174(2):280-91. PubMed ID: 27018199
[TBL] [Abstract][Full Text] [Related]
22. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
Barry E; DeAngelo DJ; Neuberg D; Stevenson K; Loh ML; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin M; Cohen HJ; Sallan SE; Silverman LB
J Clin Oncol; 2007 Mar; 25(7):813-9. PubMed ID: 17327603
[TBL] [Abstract][Full Text] [Related]
23. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia.
Mateos MK; Trahair TN; Mayoh C; Barbaro PM; Sutton R; Revesz T; Barbaric D; Giles JE; Alvaro F; Mechinaud F; Catchpoole D; Kotecha RS; Dalla-Pozza L; Quinn MCJ; MacGregor S; Chenevix-Trench G; Marshall GM
Thromb Res; 2019 Jun; 178():132-138. PubMed ID: 31030032
[TBL] [Abstract][Full Text] [Related]
25. The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia.
Grace RF; DeAngelo DJ; Stevenson KE; Neuberg D; Sallan SE; Mourad YRA; Bergeron J; Seftel MD; Kokulis C; Connors JM
J Thromb Thrombolysis; 2018 Feb; 45(2):306-314. PubMed ID: 29260426
[TBL] [Abstract][Full Text] [Related]
26. Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.
Loh ML; Goldwasser MA; Silverman LB; Poon WM; Vattikuti S; Cardoso A; Neuberg DS; Shannon KM; Sallan SE; Gilliland DG
Blood; 2006 Jun; 107(11):4508-13. PubMed ID: 16493009
[TBL] [Abstract][Full Text] [Related]
27. ABO Group as a Thrombotic Risk Factor in Children With Acute Lymphoblastic Leukemia: A Retrospective Study of 523 Patients.
Mizrahi T; Leclerc JM; David M; Ducruet T; Robitaille N
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e328-32. PubMed ID: 25851553
[TBL] [Abstract][Full Text] [Related]
28. Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen.
Chen R; Liu X; Law AD; Kanfar S; Maze D; Chan SM; Gupta V; Yee KW; Minden MD; Schimmer AD; Schuh AC; McNamara CJ; Murphy T; Xu A; Falcone U; Seki J; Sibai H
Curr Oncol; 2020 Dec; 28(1):128-137. PubMed ID: 33704181
[TBL] [Abstract][Full Text] [Related]
29. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.
Silverman LB; Gelber RD; Dalton VK; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Arkin S; Declerck L; Cohen HJ; Sallan SE
Blood; 2001 Mar; 97(5):1211-8. PubMed ID: 11222362
[TBL] [Abstract][Full Text] [Related]
30. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
Badhiwala JH; Nayiager T; Athale UH
Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia.
Elhasid R; Lanir N; Sharon R; Weyl Ben Arush M; Levin C; Postovsky S; Ben Barak A; Brenner B
Blood Coagul Fibrinolysis; 2001 Jul; 12(5):367-70. PubMed ID: 11505079
[TBL] [Abstract][Full Text] [Related]
32. A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.
Finkelstein Y; Blonquist TM; Vijayanathan V; Stevenson KE; Neuberg DS; Silverman LB; Vrooman LM; Sallan SE; Cole PD
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957785
[TBL] [Abstract][Full Text] [Related]
33. An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.
Kahn JM; Cole PD; Blonquist TM; Stevenson K; Jin Z; Barrera S; Davila R; Roberts E; Neuberg DS; Athale UH; Clavell LA; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJG; Sallan SE; Silverman LB; Kelly KM
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29090520
[TBL] [Abstract][Full Text] [Related]
34. [Cerebral sinovenous thrombosis in a girl with acute lymphoblastic leukaemia carrying the prothrombin G20210A variant].
González García H; Sacoto Erazo G; Moreno Gómez E; Blanco Quirós A; Fernández Abril MC; Alvarez Guisasola FJ
An Pediatr (Barc); 2013 Apr; 78(4):263-7. PubMed ID: 23047042
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness and Safety of Primary Thromboprophylaxis in Children with Cancer: A Systematic Review of the Literature and Network Meta-Analysis.
Pelland-Marcotte MC; Tole S; Pechlivanoglou P; Brandão LR
Thromb Haemost; 2019 Dec; 119(12):2034-2042. PubMed ID: 31600808
[TBL] [Abstract][Full Text] [Related]
36. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
[TBL] [Abstract][Full Text] [Related]
37. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
Goldberg JM; Silverman LB; Levy DE; Dalton VK; Gelber RD; Lehmann L; Cohen HJ; Sallan SE; Asselin BL
J Clin Oncol; 2003 Oct; 21(19):3616-22. PubMed ID: 14512392
[TBL] [Abstract][Full Text] [Related]
38. The association of mediastinal mass in the formation of thrombi in pediatric patients with non-lymphoblastic lymphomas.
Gartrell J; Kaste SC; Sandlund JT; Flerlage J; Zhou Y; Cheng C; Estepp J; Metzger ML
Pediatr Blood Cancer; 2020 Feb; 67(2):e28057. PubMed ID: 31736198
[TBL] [Abstract][Full Text] [Related]
39. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
Rank CU; Toft N; Tuckuviene R; Grell K; Nielsen OJ; Frandsen TL; Marquart HVH; Albertsen BK; Tedgård U; Hallböök H; Ruud E; Jarvis KB; Quist-Paulsen P; Huttunen P; Wartiovaara-Kautto U; Jónsson ÓG; Trakymiene SS; Griškevičius L; Saks K; Punab M; Schmiegelow K
Blood; 2018 May; 131(22):2475-2484. PubMed ID: 29661787
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]